Mr. Chunyang Shao was appointed as the Independent Non-executive Director on 23 September, 2016.
Mr. Shao is currently a partner of JunHe LLP and a member of the All China Lawyers Association and Shanghai Bar Association. Mr. Shao specializes in practice such as corporate, foreign investment, real estate, mergers and acquisitions, securities, infrastructure and project finance. From July 1988 to October 1993, Mr. Shao worked in Anhui Foreign Economy Law Office. From November 1995 to March 2002, Mr. Shao worked in the London, Hong Kong and China offices of major international law firms, including in Simmons & Simmons as PRC legal counsel and Sidley Austin as a senior PRC legal consultant. Mr. Shao joined JunHe LLP in April 2002.
From August 2018 to September 2021, Mr. Shao was an independent director of Changjiang & Jinggong Steel Building (Group) Co., Ltd. (a company listed on Shanghai Stock Exchange (stock code: 600496)). From March 2017 to December 2023, Mr. Shao was an independent director of Zhejiang Aishida Electric Co., Ltd. ( a company listed on Shenzhen Stock Exchange (stock code: 002403)). Mr. Shao is currently an independent director of Pharma Resources (Shanghai) Co., Ltd. ( a company listed on Shenzhen Stock Exchange, (stock code: 301230)), Brite Semiconductor (Shanghai) Co., Ltd. ( a company listed on STAR market of Shanghai Stock Exchange (stock code: 688691)), and LakeShore Biopharma Co., Ltd., a company listed on NASDAQ (stock code: LSB).
Mr. Shao received his bachelor degree in law from East China University of Political Science and Law in 1987, and was admitted to practice PRC law in 1988. From 1993 to 1994, Mr. Shao worked as visiting lawyer in Sino-Britain Young Lawyers' Exchange Program in the UK. In 2002, he received his master degree in law from East China University of Political Science and Law.